Johnson & Johnson COVID Vaccine Administration Resumes In Philly

PHILADELPHIA — The Johnson & Johnson coronavirus vaccine is once again being administered in Philadelphia, officials announced Monday.

The announcement comes about two weeks after the CDC recommended pausing Johnson & Johnson's vaccine administration after six people who got the vaccine suffered blood clotting issues.

In a news release Monday, officials said the health department and the CDC feel the risk of this clotting issue is very small, and the vaccine still provides excellent protection against the virus.

The health department notified all vaccine providers in the city that they are allowed to begin administering the Johnson & Johnson vaccine again.

On Friday, the CDC re-approved the use of Johnson & Johnson.

The CDC also issued an updated fact sheet for recipients and caregivers that detail symptoms that people receiving the vaccine should be aware of. These symptoms include:

• Shortness of breath,
• Chest pain,
• Leg swelling,
• Persistent abdominal pain,
• Severe or persistent headaches or blurred vision,
• Easy bruising or tiny blood spots under the skin beyond the site of the injection.

Those who got the Johnson & Johnson vaccine within the last two weeks and experience any of those symptoms should seek medical attention immediately.

As of Monday, 735,788 people in Philadelphia have been partially vaccinated and 487,961 people have been fully vaccinated.